Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.35 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6703054 | 1.00 | HIF1A (0.52) | HIF1APKMPARP14PARP10PTGS2 | |
| SCHEMBL7498106 | 0.91 | HIF1A (0.51) | HIF1APKMPTGS2GAA | |
| SCHEMBL7492770 | 0.91 | HIF1A (0.51) | HIF1APKMPARP14PARP10PTGS2 | |
| SCHEMBL7504404 | 0.90 | HIF1A (0.53) | HIF1APKMPARP14PARP10GAA | |
| SCHEMBL7524544 | 0.90 | HIF1A (0.40) | HIF1APKMPARP14PARP10 | |
| SCHEMBL7502688 | 0.88 | HIF1A (0.55) | HIF1APARP14PARP10 | |
| SCHEMBL7501613 | 0.87 | HIF1A (0.54) | HIF1APARP14PARP10 | |
| SCHEMBL25720630 | 0.84 | HIF1A (0.54) | HIF1APKM | |
| SCHEMBL8444521 | 0.83 | HIF1A (0.60) | HIF1APKMPTGS2 | |
| SCHEMBL8444517 | 0.83 | HIF1A (0.60) | HIF1APKMPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077895-A1 | Process for the preparation of strobilurin intermediates | WADITSCHATKA RUDOLF (CH) | 2004-04-22 | — | — | US | disclosed |
| US-6664422-B1 | Process for the preparation of strobilurin intermediates | BAYER AKTIENGESELLSCHAFT (DE) | 2003-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077895-A1 | Process for the preparation of strobilurin intermediates | TET1, CYP1B1, STS | HIF1A 1841/4885PKM 1252/4885PARP14 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.